119 related articles for article (PubMed ID: 38697493)
21. OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma.
Gao M; Yeh PY; Lu YS; Hsu CH; Chen KF; Lee WC; Feng WC; Chen CS; Kuo ML; Cheng AL
Cancer Res; 2008 Nov; 68(22):9348-57. PubMed ID: 19010909
[TBL] [Abstract][Full Text] [Related]
22. Suppression of DRP1‑mediated mitophagy increases the apoptosis of hepatocellular carcinoma cells in the setting of chemotherapy.
Ma M; Lin XH; Liu HH; Zhang R; Chen RX
Oncol Rep; 2020 Mar; 43(3):1010-1018. PubMed ID: 32020220
[TBL] [Abstract][Full Text] [Related]
23. Human menstrual blood-derived stem cells reverse sorafenib resistance in hepatocellular carcinoma cells through the hyperactivation of mitophagy.
Zhou S; Liu Y; Zhang Q; Xu H; Fang Y; Chen X; Fu J; Yuan Y; Li Y; Yuan L; Xiang C
Stem Cell Res Ther; 2023 Apr; 14(1):58. PubMed ID: 37005657
[TBL] [Abstract][Full Text] [Related]
24. Anti‑cancer effects of a novel Pan‑RAF inhibitor in a hepatocellular carcinoma cell line.
Wang W; Xu B; Li Q; Jiang D; Yan S
Mol Med Rep; 2018 Apr; 17(4):6185-6193. PubMed ID: 29484394
[TBL] [Abstract][Full Text] [Related]
25. Methyl gallate, gallic acid-derived compound, inhibit cell proliferation through increasing ROS production and apoptosis in hepatocellular carcinoma cells.
Huang CY; Chang YJ; Wei PL; Hung CS; Wang W
PLoS One; 2021; 16(3):e0248521. PubMed ID: 33725002
[TBL] [Abstract][Full Text] [Related]
26.
Huang XF; Sheu GT; Chang KF; Huang YC; Hung PH; Tsai NM
Molecules; 2020 Nov; 25(23):. PubMed ID: 33266043
[TBL] [Abstract][Full Text] [Related]
27. OPA1 downregulation is involved in sorafenib-induced apoptosis in hepatocellular carcinoma.
Zhao X; Tian C; Puszyk WM; Ogunwobi OO; Cao M; Wang T; Cabrera R; Nelson DR; Liu C
Lab Invest; 2013 Jan; 93(1):8-19. PubMed ID: 23108376
[TBL] [Abstract][Full Text] [Related]
28. Rage induces hepatocellular carcinoma proliferation and sorafenib resistance by modulating autophagy.
Li J; Wu PW; Zhou Y; Dai B; Zhang PF; Zhang YH; Liu Y; Shi XL
Cell Death Dis; 2018 Feb; 9(2):225. PubMed ID: 29445087
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of autophagic flux by salinomycin results in anti-cancer effect in hepatocellular carcinoma cells.
Klose J; Stankov MV; Kleine M; Ramackers W; Panayotova-Dimitrova D; Jäger MD; Klempnauer J; Winkler M; Bektas H; Behrens GM; Vondran FW
PLoS One; 2014; 9(5):e95970. PubMed ID: 24816744
[TBL] [Abstract][Full Text] [Related]
30. Cotreatment with sorafenib and oleanolic acid induces reactive oxygen species-dependent and mitochondrial-mediated apoptotic cell death in hepatocellular carcinoma cells.
Liese J; Hinrichs TM; Lange M; Fulda S
Anticancer Drugs; 2019 Mar; 30(3):209-217. PubMed ID: 30640794
[TBL] [Abstract][Full Text] [Related]
31. MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma.
Xia P; Zhang H; Xu K; Jiang X; Gao M; Wang G; Liu Y; Yao Y; Chen X; Ma W; Zhang Z; Yuan Y
Cell Death Dis; 2021 Jul; 12(7):691. PubMed ID: 34244479
[TBL] [Abstract][Full Text] [Related]
32. Enhancing anti-tumor efficiency in hepatocellular carcinoma through the autophagy inhibition by miR-375/sorafenib in lipid-coated calcium carbonate nanoparticles.
Zhao P; Li M; Wang Y; Chen Y; He C; Zhang X; Yang T; Lu Y; You J; Lee RJ; Xiang G
Acta Biomater; 2018 May; 72():248-255. PubMed ID: 29555460
[TBL] [Abstract][Full Text] [Related]
33. miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy.
Xu WP; Liu JP; Feng JF; Zhu CP; Yang Y; Zhou WP; Ding J; Huang CK; Cui YL; Ding CH; Zhang X; Lu B; Xie WF
Gut; 2020 Jul; 69(7):1309-1321. PubMed ID: 31727683
[TBL] [Abstract][Full Text] [Related]
34. RNA m
Lin Z; Niu Y; Wan A; Chen D; Liang H; Chen X; Sun L; Zhan S; Chen L; Cheng C; Zhang X; Bu X; He W; Wan G
EMBO J; 2020 Jun; 39(12):e103181. PubMed ID: 32368828
[TBL] [Abstract][Full Text] [Related]
35. CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.
Karkampouna S; van der Helm D; Gray PC; Chen L; Klima I; Grosjean J; Burgmans MC; Farina-Sarasqueta A; Snaar-Jagalska EB; Stroka DM; Terracciano L; van Hoek B; Schaapherder AF; Osanto S; Thalmann GN; Verspaget HW; Coenraad MJ; Kruithof-de Julio M
J Pathol; 2018 Jul; 245(3):297-310. PubMed ID: 29604056
[TBL] [Abstract][Full Text] [Related]
36. Imatinib inhibits the malignancy of hepatocellular carcinoma by suppressing autophagy.
Xiao MC; Qian H; Huang CK; Zheng BN; Yan FZ; Liu F; Zhang X; Chen SJ; Luo C; Xie WF
Eur J Pharmacol; 2021 Sep; 906():174217. PubMed ID: 34087223
[TBL] [Abstract][Full Text] [Related]
37. TAK1 Is a Novel Target in Hepatocellular Carcinoma and Contributes to Sorafenib Resistance.
Xia S; Ji L; Tao L; Pan Y; Lin Z; Wan Z; Pan H; Zhao J; Cai L; Xu J; Cai X
Cell Mol Gastroenterol Hepatol; 2021; 12(3):1121-1143. PubMed ID: 33962073
[TBL] [Abstract][Full Text] [Related]
38. Dual effects of gossypol on human hepatocellular carcinoma via endoplasmic reticulum stress and autophagy.
Zhang G; Wang Z; Chen W; Cao Y; Wu J; Qiang G; Ji A; Wu J; Jiang C
Int J Biochem Cell Biol; 2019 Aug; 113():48-57. PubMed ID: 31128260
[TBL] [Abstract][Full Text] [Related]
39. A novel multitarget kinase inhibitor BZG with potent anticancer activity in vitro and vivo enhances efficacy of sorafenib through PI3K pathways in hepatocellular carcinoma cells.
Wang L; Zhan Y; Wu Z; Lin M; Jin X; Jiang L; Qiu Y
Biomed Pharmacother; 2020 May; 125():110033. PubMed ID: 32187962
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial pathway mediated by reactive oxygen species involvement in α-hederin-induced apoptosis in hepatocellular carcinoma cells.
Li J; Wu DD; Zhang JX; Wang J; Ma JJ; Hu X; Dong WG
World J Gastroenterol; 2018 May; 24(17):1901-1910. PubMed ID: 29740205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
